Stepscan Technologies Inc. to participate in Canadian Technology Accelerator Health IT Philadelphia

CHARLOTTETOWN, PE – (October 3, 2017) – Stepscan Technologies Inc. is excited to be selected as one of six Canadian companies to be a part of Canadian Technology Accelerator’s Health IT (CTA HIT) Fall Cohort 2017. CTA helps to connect Canadian technology companies to U.S. markets, providing opportunities for investment and partnerships. Their six-month HIT program focuses on Philadelphia as a hub for the healthcare service market.

“The company has participated in a few programs, like 48 Hours in the HUB”, Stepscan President and CEO, Crystal Trevors, explains. “Hopefully working with CTA will help to increase our presence in the US market”. Trevors will travel to Philadelphia mid-October to launch the six-month intensive CTA Bootcamp, with monthly trips anticipated between then and March 2018.

In September of this year, Stepscan Technologies upgraded to Version 2.1 of their Stepscan® gait analysis software. This newest version features multiple report enhancements and improved data sharing capabilities. The clinician-friendly technology is poised to make an impact in the American healthcare market.

About StepscanStepscan Technologies Inc. is a federally incorporated Canadian technology company dedicated to the development and commercialization of its two patents in the field of movement tracking and analysis. The company’s pressure sensitive flooring system has many applications beyond medical research and clinical rehabilitation, including sports training and clinical drug trials, as well as military training /virtual simulation and security. Stepscan Technologies is one of over 45 companies that make up the Prince Edward Island Bioscience Cluster.

StepScan®

Stepscan Technologies Inc. is a Canadian technology company located on the East coast in the Province of Prince Edward Island. Its primary product, the Stepscan Gait Analysis flooring system, is medical grade equipment that is currently marketed and sold in Canada, the US, Australia, Mexico and China.